194 related articles for article (PubMed ID: 19937272)
1. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
4. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of TGF-β signaling pathway in breast cancer patients.
de Kruijf EM; Dekker TJA; Hawinkels LJAC; Putter H; Smit VTHBM; Kroep JR; Kuppen PJK; van de Velde CJH; Ten Dijke P; Tollenaar RAEM; Mesker WE
Ann Oncol; 2013 Feb; 24(2):384-390. PubMed ID: 23022998
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.
Buck MB; Fritz P; Dippon J; Zugmaier G; Knabbe C
Clin Cancer Res; 2004 Jan; 10(2):491-8. PubMed ID: 14760070
[TBL] [Abstract][Full Text] [Related]
8. Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.
Su Y; Cai H; Zheng Y; Qiu Q; Lu W; Shu XO; Cai Q
Am J Epidemiol; 2016 Oct; 184(7):501-509. PubMed ID: 27651382
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
12. Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours.
Paiva CE; Drigo SA; Rosa FE; Moraes Neto FA; Caldeira JRF; Soares FA; Domingues MAC; Rogatto SR
Ann Oncol; 2010 Apr; 21(4):734-740. PubMed ID: 19914962
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice.
Luckett-Chastain LR; Gallucci RM
Br J Dermatol; 2009 Aug; 161(2):237-48. PubMed ID: 19438433
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
Bierie B; Chung CH; Parker JS; Stover DG; Cheng N; Chytil A; Aakre M; Shyr Y; Moses HL
J Clin Invest; 2009 Jun; 119(6):1571-82. PubMed ID: 19451693
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
17. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
19. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
20. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
